Literature DB >> 2423543

Early response pattern analysis of the mitogenic pathway in lymphocytes and fibroblasts.

J C Metcalfe, T R Hesketh, G A Smith, J D Morris, A N Corps, J P Moore.   

Abstract

The early biochemical responses stimulated by the action of mitogens and growth factors on mouse thymocytes and 3T3 fibroblasts are analysed as part of a systematic attempt to define the mitogenic pathways from G0 to S phase in these cells. Although the primary response to each mitogen can be distinguished by the pattern of secondary responses they initiate, there is substantial overlap in these responses. The aim is therefore to determine whether there is early convergence on a common mitogenic pathway, defined by a sequence of responses obligatory for progression from G0 to S phase for different mitogens and cell types. The 'dual-signal' hypothesis for the mitogenic stimulation of thymocytes is a simple version of a common mitogenic pathway. It proposes that the T-cell receptor initiates the pathway via the breakdown of phosphatidylinositol (4,5)-bisphosphate to generate a Ca signal (from the release of inositol (1,4,5)-trisphosphate) and to activate protein kinase C (from the release of diacylglycerol). The rationale for this hypothesis lies in the co-mitogenic action of the Ca2+-ionophore, A23187, and the phorbol ester, 12-o-tetradecanoyl phorbol 13-acetate, which is assumed to activate specifically protein kinase C. However, detailed analysis of the coupling between some of the early responses, including the Ca and pH signals, phosphatidylinositol (4,5)-bisphosphate metabolism, c-myc gene activation and general metabolic stimulation, indicates clearly that the hypothesis is inadequate to account for the initiation of the normal mitogenic pathway in thymocytes.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 2423543     DOI: 10.1242/jcs.1985.supplement_3.19

Source DB:  PubMed          Journal:  J Cell Sci Suppl        ISSN: 0269-3518


  9 in total

1.  NIH-3T3 cells transformed with a ras oncogene exhibit a protein kinase C-mediated inhibition of agonist-stimulated Ca2+ inflow.

Authors:  A J Polverino; B P Hughes; G J Barritt
Journal:  Biochem J       Date:  1990-10-15       Impact factor: 3.857

Review 2.  Calcium, cyclic AMP and protein kinase C--partners in mitogenesis.

Authors:  J F Whitfield; J P Durkin; D J Franks; L P Kleine; L Raptis; R H Rixon; M Sikorska; P R Walker
Journal:  Cancer Metastasis Rev       Date:  1987       Impact factor: 9.264

3.  Abnormal protein kinase C down regulation and reduced substrate levels in non-phorbol ester-responsive 3T3-TNR9 cells.

Authors:  H P Biemann; R L Erikson
Journal:  Mol Cell Biol       Date:  1990-05       Impact factor: 4.272

4.  Mitogenic stimulation transiently increases the exchangeable mitochondrial calcium pool in rat thymocytes.

Authors:  P L Lakin-Thomas; M D Brand
Journal:  Biochem J       Date:  1987-08-15       Impact factor: 3.857

5.  Differential control of proto-oncogene c-myc and c-fos expression in lymphocytes and fibroblasts.

Authors:  R McNerney; D Darling; A Johnstone
Journal:  Biochem J       Date:  1987-07-15       Impact factor: 3.857

6.  Differential effects of the calcium ionophore A23187 and the phorbol ester PMA on lymphocyte proliferation.

Authors:  D Planelles; J Hernández-Godoy; A González-Molina
Journal:  Agents Actions       Date:  1992-03

7.  C-terminal bombesin sequence requirements for binding and effects on protein synthesis in Swiss 3T3 cells.

Authors:  S E Gargosky; J C Wallace; F M Upton; F J Ballard
Journal:  Biochem J       Date:  1987-10-15       Impact factor: 3.857

8.  Phosphoinositide metabolism and the calcium response to concanavalin A in S49 T-lymphoma cells. A comparison with thymocytes.

Authors:  M V Taylor; T R Hesketh; J C Metcalfe
Journal:  Biochem J       Date:  1988-02-01       Impact factor: 3.857

Review 9.  The Role for Myc in Coordinating Glycolysis, Oxidative Phosphorylation, Glutaminolysis, and Fatty Acid Metabolism in Normal and Neoplastic Tissues.

Authors:  Eric S Goetzman; Edward V Prochownik
Journal:  Front Endocrinol (Lausanne)       Date:  2018-04-12       Impact factor: 5.555

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.